BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 22146611)

  • 1. The time course and phenotype of Uhthoff phenomenon following optic neuritis.
    Fraser CL; Davagnanam I; Radon M; Plant GT
    Mult Scler; 2012 Jul; 18(7):1042-4. PubMed ID: 22146611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifocal visual evoked potential latency analysis: predicting progression to multiple sclerosis.
    Fraser C; Klistorner A; Graham S; Garrick R; Billson F; Grigg J
    Arch Neurol; 2006 Jun; 63(6):847-50. PubMed ID: 16769865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group.
    Beck RW; Cleary PA; Trobe JD; Kaufman DI; Kupersmith MJ; Paty DW; Brown CH
    N Engl J Med; 1993 Dec; 329(24):1764-9. PubMed ID: 8232485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome measures for trials of remyelinating agents in multiple sclerosis: retrospective longitudinal analysis of visual evoked potential latency.
    Niklas A; Sebraoui H; Hess E; Wagner A; Then Bergh F
    Mult Scler; 2009 Jan; 15(1):68-74. PubMed ID: 18701569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression of visual evoked potential abnormalities in multiple sclerosis and optic neuritis.
    Alshuaib WB
    Electromyogr Clin Neurophysiol; 2000 Jun; 40(4):243-52. PubMed ID: 10907603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study of visual evoked potentials in optic neuritis and optic neuritis with multiple sclerosis.
    Samsen P; Chuenkongkaew WL; Masayaanon P; Chirapapaisan N; Ruangvaravate N; Loket S
    J Med Assoc Thai; 2007 Feb; 90(2):313-8. PubMed ID: 17375637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The National Eye Institute Visual Function Questionnaire: experience of the ONTT. Optic Neuritis Treatment Trial.
    Cole SR; Beck RW; Moke PS; Gal RL; Long DT
    Invest Ophthalmol Vis Sci; 2000 Apr; 41(5):1017-21. PubMed ID: 10752936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution of visual evoked potentials in optic neuritis.
    Heinrichs IH; McLean DR
    Can J Neurol Sci; 1988 Nov; 15(4):394-6. PubMed ID: 3208223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Spatial contrast sensitivity in multiple sclerosis].
    Vighetto A; Grochowicki M; Cousin J
    Rev Neurol (Paris); 1990; 146(4):264-70. PubMed ID: 2359900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A risk of developing multiple sclerosis following an outbreak of optic neuritis during a mean follow-up of 4.5 years].
    Deyá E; Sevilla T; Coret F
    Neurologia; 1998 Oct; 13(8):377-81. PubMed ID: 9859669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between morphological and functional retinal impairment in multiple sclerosis patients.
    Parisi V; Manni G; Spadaro M; Colacino G; Restuccia R; Marchi S; Bucci MG; Pierelli F
    Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2520-7. PubMed ID: 10509645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiological evidence for heterogeneity of lesions in optic neuritis.
    Klistorner A; Graham S; Fraser C; Garrick R; Nguyen T; Paine M; O'Day J; Grigg J; Arvind H; Billson FA
    Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4549-56. PubMed ID: 17898277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uhthoff and his symptom.
    Selhorst JB; Saul RF
    J Neuroophthalmol; 1995 Jun; 15(2):63-9. PubMed ID: 7550931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A neuro-ophthalmological analysis in 80 cases of multiple sclerosis].
    Tsuda H; Ishikawa H; Matsunaga H; Mizutani T
    Rinsho Shinkeigaku; 2004 Aug; 44(8):513-21. PubMed ID: 15471086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Optic neuritis as the first sign of multiple sclerosis].
    Szilasiová J; Klímová E; Veselá D
    Cesk Slov Oftalmol; 2002 Jul; 58(4):259-64. PubMed ID: 12181882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mtDNA haplogroup J: a contributing factor of optic neuritis.
    Reynier P; Penisson-Besnier I; Moreau C; Savagner F; Vielle B; Emile J; Dubas F; Malthièry Y
    Eur J Hum Genet; 1999 Apr; 7(3):404-6. PubMed ID: 10234520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features and outcome of childhood optic neuritis at Queen Sirikit National Institute of Child Health.
    Sri-udomkajorn S; Pongwatcharaporn K
    J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S189-94. PubMed ID: 22043775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bilateral and recurrent optic neuritis in multiple sclerosis.
    Burman J; Raininko R; Fagius J
    Acta Neurol Scand; 2011 Mar; 123(3):207-10. PubMed ID: 20569226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors likely to affect the development of multiple sclerosis in patients presenting with optic neuritis in a tropical and subtropical area.
    Landy PJ; Innis M; Boyle R
    Clin Exp Neurol; 1979; 16():175-82. PubMed ID: 550939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolving management of optic neuritis and multiple sclerosis.
    Arnold AC
    Am J Ophthalmol; 2005 Jun; 139(6):1101-8. PubMed ID: 15953446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.